Streetbeat News

Price Targets

BE

Bloom Energy reported disappointing Q3 results, missing expectations due to project delays. Despite this, management maintains aggressive full-year projections. Analysts have lowered price targets, but shares rose by 30% due to excitement over AI data center opportunities.

Portfolio Pulse from

November 12, 2024 | 1:00 am

^GSPC

IVV

Yardeni Research has increased its S&P 500 targets for 2024, 2025, and 2026 following Donald Trump's reelection. Ed Yardeni expresses optimism about market performance with Trump's second term.

Portfolio Pulse from

November 11, 2024 | 11:00 pm

DY

Dycom Industries is recommended as a solid stock to buy due to its strong performance in 2024 and potential growth from the BEAD program. The company has a BUY rating with a target price of $389.68 for FY 2027, driven by its relationships with major telecom providers and geographical presence.

Portfolio Pulse from

November 11, 2024 | 9:30 pm

BMBL

BofA Securities analyst Curtis Nagle has reiterated an Underperform rating on Bumble Inc (BMBL), while slightly increasing the price target from $5.50 to $5.75. Despite efficiency gains, growth risks are flagged.

Portfolio Pulse from

November 11, 2024 | 7:00 pm

DVAX

Wall Street analysts predict a significant upside potential of 88.32% for Dynavax Technologies (DVAX), driven by upward trends in earnings estimate revisions.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

ZK

Wall Street analysts predict a 27.79% upside for Zeekr (ZK) based on average price targets. Positive earnings estimate revisions could support this potential increase.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

LTM

Analysts predict a potential 40.6% upside for LATAM (LTM) stock, with strong agreement in raising earnings estimates indicating a positive outlook.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

VERA

Wall Street analysts suggest a potential 27.3% upside for Vera Therapeutics (VERA) based on consensus price targets. Despite skepticism about the effectiveness of price targets, positive earnings estimate revisions could indicate a near-term stock price increase.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

THRD

Wall Street analysts have set an average price target for Third Harmonic Bio, Inc. (THRD) that suggests a potential upside of 26.7%. This optimism is supported by positive trends in earnings estimate revisions.

Portfolio Pulse from

November 11, 2024 | 4:15 pm

BUR

Wall Street analysts have set a mean price target for Burford Capital (BUR) that suggests a potential 42.6% upside. Despite the historical inaccuracy of such metrics, the consensus among analysts in raising earnings estimates supports a positive outlook for BUR.

Portfolio Pulse from

November 11, 2024 | 4:15 pm